Literature DB >> 25422026

Growth hormone therapy, muscle thickness, and motor development in Prader-Willi syndrome: an RCT.

Linda Reus1, Sigrid Pillen2, Ben J Pelzer3, Janielle A A E M van Alfen-van der Velden4, Anita C S Hokken-Koelega5, Machiel Zwarts6, Barto J Otten4, Maria W G Nijhuis-van der Sanden7.   

Abstract

OBJECTIVE: To investigate the effect of physical training combined with growth hormone (GH) on muscle thickness and its relationship with muscle strength and motor development in infants with Prader-Willi syndrome (PWS).
METHODS: In a randomized controlled trial, 22 infants with PWS (12.9 ± 7.1 months) were followed over 2 years to compare a treatment group (n = 10) with a waiting-list control group (n = 12). Muscle thickness of 4 muscle groups was measured by using ultrasound. Muscle strength was evaluated by using the Infant Muscle Strength meter. Motor performance was measured with the Gross Motor Function Measurement. Analyses of variance were used to evaluate between-group effects of GH on muscle thickness at 6 months and to compare pre- and posttreatment (after 12 months of GH) values. Multilevel analyses were used to evaluate effects of GH on muscle thickness over time, and multilevel bivariate analyses were used to test relationships between muscle thickness, muscle strength, and motor performance.
RESULTS: A significant positive effect of GH on muscle thickness (P < .05) was found. Positive relationships were found between muscle thickness and muscle strength (r = 0.61, P < .001), muscle thickness and motor performance (r = 0.81, P < .001), and muscle strength and motor performance (r = 0.76, P < .001).
CONCLUSIONS: GH increased muscle thickness, which was related to muscle strength and motor development in infants with PWS. Catch-up growth was faster in muscles that are most frequently used in early development. Because this effect was independent of GH, it suggests a training effect.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  Prader-Willi syndrome; body composition; growth hormone; infants; motor development; muscle development

Mesh:

Substances:

Year:  2014        PMID: 25422026     DOI: 10.1542/peds.2013-3607

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Gait strategy and body composition in patients with Prader-Willi syndrome.

Authors:  Veronica Cimolin; Nicola Cau; Manuela Galli; Massimiliano Pau; Cinzia Parisio; Antonella Saezza; Graziano Grugni; Paolo Capodaglio
Journal:  Eat Weight Disord       Date:  2019-12-04       Impact factor: 4.652

Review 2.  Endocrine disorders and the neurologic manifestations.

Authors:  Jeesuk Yu
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-12-31

Review 3.  Prader-Willi Syndrome: The Disease that Opened up Epigenomic-Based Preemptive Medicine.

Authors:  Takeo Kubota; Kunio Miyake; Natsuyo Hariya; Vuong Tran Nguyen Quoc; Kazuki Mochizuki
Journal:  Diseases       Date:  2016-03-11

Review 4.  Epigenetic alterations induced by environmental stress associated with metabolic and neurodevelopmental disorders.

Authors:  Takeo Kubota
Journal:  Environ Epigenet       Date:  2016-08-08

5.  Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.

Authors:  Aram Yang; Jin-Ho Choi; Young Bae Sohn; Yunae Eom; Jiyoon Lee; Han-Wook Yoo; Dong-Kyu Jin
Journal:  Orphanet J Rare Dis       Date:  2019-09-11       Impact factor: 4.123

6.  Health Problems in Individuals With PWS Are Associated With Lower Quality of Life for Their Parents: A Snapshot in the Brazilian Population.

Authors:  Alexandre Slowetzky Amaro; Daniela Andrea Rubin; Maria Cristina Triguero Veloz Teixeira; Arcenio José Ferreira; Graciele Massoli Rodrigues; Luiz Renato Rodrigues Carreiro
Journal:  Front Pediatr       Date:  2022-02-15       Impact factor: 3.418

7.  Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis.

Authors:  Caroline de Gouveia Buff Passone; Ruth Rocha Franco; Simone Sakura Ito; Evelinda Trindade; Michel Polak; Durval Damiani; Wanderley Marques Bernardo
Journal:  BMJ Paediatr Open       Date:  2020-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.